96
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Successful asymmetrical deep brain stimulation using right subthalamic and left pallidal electrodes in a patient with Parkinson’s disease

, , , , , & show all
Pages 356-360 | Received 23 Jan 2019, Accepted 11 Jan 2021, Published online: 21 Jan 2021

References

  • Fasano A, Daniele A, Albanese A. Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. Lancet Neurol 2012;11:429–42.
  • Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. Journal of Neurophysiology 1994;72:521–30.
  • Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436–8.
  • Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 2005;62:554–60.
  • Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 2010;362:2077–91.
  • Krause M, Fogel W, Heck A, et al. Deep brain stimulation for the treatment of Parkinson’s disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 2001;70:464–70.
  • Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, Lang AE, Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. New Eng J Med 2001;345:956–63.
  • Okun MS, Foote KD. Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return? Arch Neurol 2005;62:533–6.
  • Ramirez-Zamora A, Ostrem JL. Globus pallidus interna or subthalamic nucleus deep brain stimulation for Parkinson disease: a review. JAMA Neurol 2018;75:367–72.
  • Zrinzo L, Foltynie T, Limousin P, Hariz MI. Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. JNS 2012;116:84–94.
  • Goetz CG, Poewe W, Rascol O, et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations the Movement Disorder Society Task Force on rating scales for Parkinson’s disease. Mov Disord 2004;19:1020–8.
  • Fahn S, Elton R. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Caine DB, eds. Recent developments in Parkinson’s disease, Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153–63; 293–304.
  • Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 1997;26:353–7.
  • Zrinzo L, Holl EM, Petersen EA, Limousin P, Foltynie T, Hariz MI. Skewering the subthalamic nucleus via a parietal approach. Stereotact Funct Neurosurg 2011;89:70–5.
  • Antonini A, Tolosa E, Mizuno Y, Yamamoto M, Poewe WH. A reassessment of risks and benefits of dopamine agonists in Parkinson’s disease. Lancet Neurol 2009;8:929–37.
  • Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008;7:605–14.
  • Campbell MC, Karimi M, Weaver PM, et al. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia 2008;46:3162–9.
  • Mazzone P, Stocchi F, Galati S, et al. Bilateral implantation of centromedian-parafascicularis complex and GPi: a new combination of unconventional targets for deep brain stimulation in severe Parkinson disease. Neuromodulation 2006;9:221–8.
  • Stefani A, Peppe A, Pierantozzi M, et al. Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. Brain Res Bull 2009;78:113–8.
  • Oertel MF, Schüpbach WM, Ghika JA, et al. Combined thalamic and subthalamic deep brain stimulation for tremor-dominant Parkinson’s disease. Acta Neurochir 2017;159:265–9.
  • Goulenko V, da Costa Cruz PL, Niemeyer Filho P. Unilateral thalamic and pallidal deep brain stimulation for idiopathic hemidystonia: results of individual and combined stimulations. Case report. Neurosurg Focus 2017;43:E2.
  • Nazzaro JM, Lyons KE, Pahwa R. Deep brain stimulation for essential tremor. Handb Clin Neurol 2013;116:155–66.
  • Mallory GW, Abulseoud O, Hwang SC, et al. The nucleus accumbens as a potential target for central poststroke pain. Mayo Clin Proc 2012;87:1025–31.
  • Sung VW, Watts RL, Schrandt CJ, et al. The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease. J Neurosurg 2013;119:1530–6.
  • Honey CR, Hamani C, Kalia SK, et al. Deep brain stimulation target selection for Parkinson’s disease. Can J Neurol Sci 2017;44:3–8.
  • Alberts JL, Hass CJ, Vitek JL, Okun MS. Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson’s disease. Exp Neurol 2008a;214:1–5.
  • Toleikis JR, Metman LV, Pilitsis JG, Barborica A, Toleikis SC, Bakay RA. Effect of intraoperative subthalamic nucleus DBS on human single-unit activity in the ipsilateral and contralateral subthalamic nucleus. JNS 2012;116:1134–43.
  • Shenai MB, Romeo A, Walker HC, Guthrie S, Watts RL, Guthrie BL. Spatial topographies of unilateral subthalamic nucleus deep brain stimulation efficacy for ipsilateral, contralateral, midline, and total Parkinson disease motor symptoms. Operative Neurosurg 2015;11:80–8.
  • Wiesendanger M, Rouiller EM, Kazennikov O, Perrig S. Is the supplementary motor area a bilaterally organized system? Adv Neurol 1996;70:85–93.
  • Léhericy S, Ducros M, Krajník A, et al. 3-D diffusion tensor axonal tracking shows distinct SMA and pre-SMA projections to the human striatum. Cereb Cortex 2004;14:1302–9.
  • Arai N, Yokochi F, Ohnishi T, et al. Mechanisms of unilateral STN-DBS in patients with Parkinson’s disease: a PET study. J Neurol 2008;255:1236–43.
  • Hazrati LN, Parent A. Contralateral pallidothalamic and pallidotegmental projections in primates: an anterograde and retrograde labeling study. Brain Res 1991;567:212–23.
  • Castle M, Aymerich MS, Sanchez-Escobar C, Gonzalo N, Obeso JA, Lanciego JL. Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: ipsi- and contralateral projections. J Comp Neurol 2005;483:143–53.
  • Lavoie B, Parent A. Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. J Comp Neurol 1994;344:210–31.
  • Brun Y, Karachi C, Fernandez-Vidal S, et al. Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson’s disease. J Neurophysiol 2012;108:1575–83.
  • Davis KD, Taub E, Houle S, et al. Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med 1997;3:671–4.
  • Alberts JL, Okun MS, Vitek JL. The persistent effects of unilateral pallidal and subthalamic deep brain stimulation on force control in advanced Parkinson’s patients. Parkinsonism Relat Disord 2008 b;14:481–8.
  • Alberts JL, Elder CM, Okun MS, Vitek JL. Comparison of pallidal and subthalamic stimulation on force control in patient’s with Parkinson’s disease. Motor Control 2004;8:484–99.
  • Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson’s disease. Mov Disord 2003;18:1000–7.
  • Torres CV, Lopez-Manzanares L, Navas-Garcia M, et al. Bilateral two-stage implantation for deep brain stimulation in the treatment of bilateral idiopathic Parkinson’s disease: clinical outcomes. Rev Neurol 2018;66:1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.